ResMed Inc (BSP:R1MD34)
R$ 381 9.84 (2.65%) Market Cap: 223.72 Bil Enterprise Value: 226.25 Bil PE Ratio: 32.98 PB Ratio: 7.04 GF Score: 86/100

Resmed Inc Investor Day Transcript

Sep 08, 2021 / 08:30PM GMT
Release Date Price: R$391.16 (+17.29%)
Amy Wakeham
ResMed Inc. - VP of IR & Corporate Communications

Good morning, good afternoon and good evening to all of our investors and shareholders joining us from around the world. Welcome to ResMed's 2021 Investor Day. We're so pleased you could join us today. My name is Amy Wakeham, ResMed's Vice President of Investor Relations and Corporate Communications, and I'm going to review just a few details before I turn the day over to our speakers.

First, I'd like to let you know that we are recording today's meeting and the webcast replay, along with these slides will be posted to the Investor Relations section of our corporate website later today, and the video replay will be within 48 hours.

I do need to remind you about our forward-looking statements. The materials, presentation and discussion today may include forward-looking statements, which are subject to risks and uncertainty. Our actual results could differ, and I do encourage you to review our SEC filings for a discussion of the risks and uncertainties that could impact our business.

Let's now turn to the agenda

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot